Read the full stored bill text
HLS 26RS-778 ORIGINAL
2026 Regular Session
HOUSE BILL NO. 277
BY REPRESENTATIVE BAMBURG
DRUGS/PRESCRIPTION: Requires educational or marketing materials for prescription
drugs directed to healthcare providers to include price information
1 AN ACT
2 To enact Part VI-C of Chapter 20 of Title 37 of the Louisiana Revised Statutes of 1950, to
3 be comprised of R.S. 37:1742.11, relative to prescription drug prices; to require
4 educational or marketing materials for prescription drugs directed to healthcare
5 providers to include price information; to provide for the minimum amount of
6 information required; to provide for enforcement; and to provide for related matters.
7 Be it enacted by the Legislature of Louisiana:
8 Section 1. Part VI-C of Chapter 20 of Title 37 of the Louisiana Revised Statutes of
9 1950, comprised of R.S. 37:1742.11, is hereby enacted to read as follows:
10 PART VI-C. DISCLOSURE OF PRESCRIPTION DRUG PRICE INFORMATION
11 §1742.11. Disclosure of prescription drug price information; educational or
12 marketing materials; minimum content; violations
13 A. Any person providing educational or marketing materials regarding a
14 prescription drug to a healthcare provider with the intent that the provider may
15 prescribe the drug for use by his patients shall include price information in the
16 materials and disclose if there is a biosimilar or generic drug available for the same
17 disease state.
18 B. The price information required by this Section shall include at a minimum
19 all of the following:
20 (1) The date that the educational or marketing materials were prepared.
Page 1 of 2
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.
HLS 26RS-778 ORIGINAL
HB NO. 277
1 (2)(a) The average wholesale acquisition cost of a thirty-day supply of the
2 drug described in the materials.
3 (b) If the described drug is designed to be administered for a duration of
4 therapy less than thirty days, the proposed duration and average wholesale price for
5 that period of time.
6 C. A violation of the provisions of this Section shall constitute a prohibited
7 practice under the Unfair Trade Practices and Consumer Protection Law, R.S.
8 51:1401 et seq., and shall be subject to the enforcement provisions of that Chapter.
DIGEST
The digest printed below was prepared by House Legislative Services. It constitutes no part
of the legislative instrument. The keyword, one-liner, abstract, and digest do not constitute
part of the law or proof or indicia of legislative intent. [R.S. 1:13(B) and 24:177(E)]
HB 277 Original 2026 Regular Session Bamburg
Abstract: Requires educational or marketing materials for prescription drugs directed to
healthcare providers to include price information.
Proposed law provides that any person providing educational or marketing materials related
to a prescription drug shall inform the healthcare provider of any biosimilars or generic
drugs available for the same disease state.
Proposed law requires any person providing educational or marketing materials related to
a prescription drug to a healthcare provider with the intent that the provider may prescribe
the drug for use by his patients shall include, at a minimum, the following price information
in the materials:
(1) The date that the educational or marketing materials were prepared.
(2) The average wholesale price of a 30-day supply of the drug described in the
materials, or if the described drug is designed to be administered for a duration of
therapy less than 30 days, the proposed duration and average wholesale price for that
period of time.
Proposed law provides that a violation of proposed law constitutes a prohibited practice
under present law, the Unfair Trade Practices and Consumer Protection Law.
(Adds R.S. 37:1742.11)
Page 2 of 2
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.